Analysts think RCEL stock price could increase by 177%
Jun 12, 2025, 11:26 AM
-5.92%
What does RCEL do
AVITA Medical, headquartered in Valencia, California, specializes in point-of-care autologous skin restoration using its RECELL platform for treating burn injuries and skin defects. The company went public on March 18, 2012, and employs 207 people.
6 analysts think RCEL stock price will increase by 176.81%. The current median analyst target is $16.83 compared to a current stock price of $6.08. The lowest analysts target is $12.63 and the highest analyst target is $23.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
